Director Shareholding

Phytopharm PLC 3 December 2004 SCHEDULE 11 NOTIFICATION OF INTERESTS OF DIRECTORS AND CONNECTED PERSONS 1) NAME OF COMPANY PHYTOPHARM PLC 2) NAME OF DIRECTOR DR R P DIXEY 3) Please state whether notification indicates that it is in respect of holding of the shareholder named in 2 above or in respect of a non-beneficial interest or in the case of an individual holder if it is a holding of that person's spouse or children under the age of 18 or in respect of an non-beneficial interest AS IN 2 ABOVE 4) Name of the registered holder(s) and, if more than one holder, the number of shares held by each of them. (If notified) AS IN 2 ABOVE 5) Please state whether notification relates to a person(s) connected with the Director named in 2 above and identify the connected person(s) AS IN 2 ABOVE 6) Please state the nature of the transaction. For PEP transactions please indicate whether general/single co PEP and if discretionary/non discretionary EXERCISE OF SHARE OPTIONS UNDER THE 1996 COMPANY SHARE OPTION SCHEME 7) Number of shares/amount of stock acquired 288,889 8) Percentage of issued Class (ANY TREASURY SHARES HELD BY COMPANY SHOULD NOT BE TAKEN INTO ACCOUNT WHEN CALCULATING PERCENTAGE) 0.0068% 9) Number of shares/amount of stock disposed NONE 10) Percentage of issued Class (ANY TREASURY SHARES HELD BY COMPANY SHOULD NOT BE TAKEN INTO ACCOUNT WHEN CALCULATING PERCENTAGE) 11) Class of security ORDINARY 12) Price per share EXERCISE PRICE 45 PENCE 13) Date of transaction 3 DECEMBER 2004 14) Date company informed 3 DECEMBER 2004 15) Total holding following this notification 543,964 16) Total percentage holding of issued class following this notification (ANY TREASURY SHARES HELD BY COMPANY SHOULD NOT BE TAKEN INTO ACCOUNT WHEN CALCULATING PERCENTAGE) 0.013% IF A DIRECTOR HAS BEEN GRANTED OPTIONS BY THE COMPANY PLEASE COMPLETE THE FOLLOWING BOXES 17) Date of grant 18) Period during which or date on which exercisable 19) Total amount paid (if any) for grant of the option 20) Description of shares or debentures involved: class, number. 21) Exercise price (if fixed at time of grant) or indication that price is to be fixed at time of exercise 22) Total number of shares or debentures over which options held following this notification 23) Any additional information 24) Name of contact and telephone number for queries DR WANG CHONG 01480 437697 25) Name and signature of authorised company official responsible for making this notification Date of Notification 3 DECEMBER 2004 END This information is provided by RNS The company news service from the London Stock Exchange

Companies

Ixico (IXI)
UK 100